Where do Intellia Therapeutics's ratios come from?

Every ratio is computed from Intellia Therapeutics's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

	TTM Q1 '26	TTM Q4 '25	TTM Q3 '25	TTM Q2 '25	TTM Q1 '25
Profitability
Operating margin	-636.6%+15.1pp	-651.7%+180pp	-832.2%+137pp	-968.7%+219pp	-1,187.4%-264pp
Net margin	-597%+12.8pp	-609.9%+165pp	-774.9%+134pp	-908.5%+246pp	-1,154.1%-257pp
Returns
Return on equity	-56.3%-2.9pp	-53.5%-1.4pp	-52.1%+4.8pp	-57%+1.0pp	-57.9%-3.9pp
Return on invested capital	-62.8%-4.1pp	-58.7%+1.3pp	-60%+3.7pp	-63.7%-1.7pp	-61.9%-3.6pp
Efficiency
Asset turnover	0.1×0.0×	0.1×0.0×	0.1×0.0×	0.1×0.0×	0×0.0×
Liquidity
Current ratio	6.1×+1.0×	5.1×-1.1×	6.2×+1.0×	5.2×+0.3×	4.9×-0.9×
Leverage
Debt-to-equity	0.1×0.0×	0.1×0.0×	0.1×0.0×	0.1×0.0×	0.2×-0.1×
Per Share
Book value per share	$5.24-15.4%	$6.20-8.8%	$6.79-1.5%	$6.90-8.5%	$7.54-14.6%
Valuation
Market capitalization	$1.51B+45.4%	$1.04B-43.8%	$1.85B+87.0%	$991.29M+34.7%	$736.01M-38.0%
Price / sales	22.9×+7.5×	15.4×-16.8×	32.2×+13.5×	18.8×+2.6×	16.2×-4.4×
Price / book	2.4×+0.9×	1.6×-0.9×	2.5×+1.1×	1.4×+0.4×	0.9×-0.4×

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Where do Intellia Therapeutics's ratios come from?: Every ratio is computed from Intellia Therapeutics's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.